Bristol Myers Squibb (CELG-RI) Change in Inventory (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Change in Inventory data on file, last reported at -$14.0 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at -$14.0 million, down 108.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 99.77% YoY), and the FY2025 annual result was $184.0 million, down 62.14% from the prior year.
• Change in Inventory rose to -$14.0 million in Q1 2026 per CELG-RI's latest filing, from -$71.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $282.0 million in Q1 2023 and troughed at -$175.0 million in Q4 2024.
• A 5-year average of $86.8 million and a median of $41.0 million in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 28300.0% in 2023, then sank 188.83% in 2024.
• A 5-year view of Change in Inventory shows it stood at $41.0 million in 2022, then surged by 380.49% to $197.0 million in 2023, then plunged by 188.83% to -$175.0 million in 2024, then jumped by 59.43% to -$71.0 million in 2025, then surged by 80.28% to -$14.0 million in 2026.
• Business Quant data shows CELG-RI's Change in Inventory at -$14.0 million in Q1 2026, -$71.0 million in Q4 2025, and $90.0 million in Q3 2025.